PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21591994-2	2011	Amonafide retains cytotoxic activity even in the presence of P-glycoprotein (Pgp)-mediated multi-drug resistance (MDR), a major contributor to clinical treatment failure.	amonafide	0-9	ATP binding cassette subfamily B member 1	Homo sapiens	61-75	
21591994-2	2011	Amonafide retains cytotoxic activity even in the presence of P-glycoprotein (Pgp)-mediated multi-drug resistance (MDR), a major contributor to clinical treatment failure.	amonafide	0-9	ATP binding cassette subfamily B member 1	Homo sapiens	77-80	
21591994-3	2011	AREAS COVERED: In vitro, Pgp-mediated transport (efflux) of amonafide from myeloblasts obtained from patients with secondary acute myeloid leukemia (sAML) was significantly less than efflux of daunorubicin.	amonafide	60-69	ATP binding cassette subfamily B member 1	Homo sapiens	25-28